Precision Biosciences Inc
DTIL· Nasdaq
DTILPrecision Biosciences Inc
Filed Aug 14, 2019 · 10-Q · 45 days after period end · 0001564590-19-032150
| Metric | Q2 2019 | Q2 2018 |
|---|---|---|
| Revenue | $5.39M | $1.87M |
| Net Income | -$19.44M | -$11.83M |
| EPS Diluted | -$0.39 | -$0.75 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 14, 2019 · 45 d after period end
